LASA
Lasa Supergenerics Limited (LASA) Stock Analysis
Lasa Supergenerics Limited is an Indian pharmaceutical company manufacturing APIs and formulations across therapeutic areas. It supplies domestic and export markets with a focus on cost-competitive chemistry. The business is regulated and subject to pricing and compliance requirements. It is listed on Indian stock exchanges.
Healthcare › Drug Manufacturers - Specialty & Generic
₹5.90
-9.66% 1W | -50.50% 52W
Market Cap
30 CR
P/E Ratio
–
52W High
₹13.4
52W Low
₹5.7
Div. Yield
0%
Beta
0.6
50 DMA
₹7
200 DMA
₹7.9
Profit Margin
-253.8%
Inst. Own.
0%
⚠️ BREAKDOWN
⚠️ BREAKDOWN
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 30.56 | 24.30 | 26.66 | 22.82 | 30.84 | 39.39 | 33.08 | 39.14 | 20.01 | 3.06 | 2.20 | -0.13 | 1.23 |
| Expenses | 26.51 | 23.25 | 25.60 | 26.81 | 29.04 | 38.60 | 32.81 | 35.73 | 20.51 | 7.06 | 2.95 | 1.99 | 2.62 |
| Operating Profit | 4.05 | 1.05 | 1.06 | -3.99 | 1.80 | 0.79 | 0.27 | 3.41 | -0.50 | -4.00 | -0.75 | -2.12 | -1.39 |
| OPM % | 13.25% | 4.32% | 3.98% | -17.48% | 5.84% | 2.01% | 0.82% | 8.71% | -2.50% | -130.72% | -34.09% | -113.01% | |
| Other Income | 0.00 | 0.08 | 0.00 | -8.76 | 0.00 | 1.95 | 8.91 | -21.52 | -20.44 | 0.01 | 0.02 | -0.42 | -0.38 |
| Interest | 0.37 | 0.56 | 0.44 | 0.56 | 0.87 | 1.24 | 0.47 | 0.11 | 0.03 | 0.12 | 0.11 | 0.13 | 0.14 |
| Depreciation | 2.65 | 2.68 | 2.68 | 2.66 | 2.79 | 2.81 | 2.80 | 3.90 | 1.57 | 1.57 | 1.57 | 1.31 | 1.57 |
| Profit before tax | 1.03 | -2.11 | -2.06 | -15.97 | -1.86 | -1.31 | 5.91 | -22.12 | -22.54 | -5.68 | -2.41 | -3.98 | -3.48 |
| Tax % | 580.58% | -99.05% | -29.61% | -4.20% | 46.77% | 146.56% | 7.11% | -35.40% | -6.30% | 10.04% | 5.81% | 4.77% | 3.16% |
| Net Profit | -4.95 | -0.02 | -1.46 | -15.30 | -2.73 | -3.23 | 5.49 | -14.29 | -21.12 | -6.25 | -2.55 | -4.16 | -3.58 |
| EPS in Rs | -0.99 | -0.00 | -0.29 | -3.05 | -0.54 | -0.64 | 1.10 | -2.85 | -4.22 | -1.25 | -0.51 | -0.83 | -0.71 |
| Metric | Mar 20161m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 199 | 244 | 170 | 167 | 201 | 137 | 130 | 104 | 142 | 25 | 6 |
| Expenses | 0 | 153 | 202 | 158 | 137 | 154 | 120 | 136 | 102 | 136 | 32 | 15 |
| Operating Profit | 0 | 46 | 41 | 11 | 30 | 47 | 16 | -6 | 2 | 6 | -7 | -8 |
| OPM % | 23% | 17% | 7% | 18% | 24% | 12% | -4.9% | 2.1% | 4.4% | -29% | -130% | |
| Other Income | 0 | -24 | 3 | 0 | 0 | 0 | -8 | -18 | -9 | -11 | -21 | -1 |
| Interest | 0 | 12 | 11 | 8 | 8 | 2 | 0 | 4 | 2 | 3 | 0 | 0 |
| Depreciation | 0 | 8 | 18 | 19 | 17 | 16 | 15 | 13 | 11 | 12 | 6 | 6 |
| Profit before tax | 0 | 2 | 15 | -16 | 5 | 30 | -6 | -42 | -19 | -19 | -35 | -16 |
| Tax % | -10% | 19% | -25% | 23% | 23% | -13% | -9% | 14% | -24% | -2% | ||
| Net Profit | 0 | 2 | 12 | -12 | 4 | 23 | -5 | -39 | -22 | -15 | -34 | -17 |
| EPS in Rs | 5.40 | -5.26 | 0.89 | 5.60 | -1.31 | -7.71 | -4.34 | -2.95 | -6.80 | -3.30 | ||
| Dividend Payout % | 0% | 0% | 0% | 0% | 4% | -24% | 0% | 0% | 0% | 0% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | -42.0% | -34.0% | – |
| Profit CAGR | 10.0% | – | – |
Shareholding Pattern
Promoters53.65%
Public46.35%
Promoters53.65%
FIIs0.47%
Public45.88%
Promoters53.65%
Public46.35%
Promoters53.65%
Public46.34%
Promoters53.65%
Public46.35%
Promoters43.78%
Public56.21%
Promoters53.65%
Public46.34%
Promoters53.65%
FIIs0.12%
Public46.23%
Promoters53.65%
Public46.35%
Promoters53.65%
Public46.35%
LASA
Holdings Analysis
Key strengths & risk signals
40
Overall
26
Fundamental
54
Technical
Risks (4)
Cannot calculate PEG - insufficient growth data.
POOR YEAR! Stock declined 50.5% in the last year.
WEAK POSITION! Current price (5.9) is below both moving averages.
WEAK! Trading at 2.6% of 52W range - near yearly lows.
Strengths (3)
OVERSOLD! RSI at 18.7 - potential bounce opportunity.
LOW VOLATILITY! Beta of 0.60 - stable stock, less market risk.
BULLISH SENTIMENT! In last 30 days: 10 up days, 15 down days. Avg volume on up days: 41,453 vs down days: 31,581. Ratio: 1.31x
Fundamental & Technical Analysis
40Overall
26Fundamental
54Technical
Fundamental Breakdown
Growth Quality
4/30
Revenue CAGR: -42.1% (DECLINING, 2/15). Profit CAGR: 0% (DECLINING, 2/15).
Profit Margin
2/10
LOW MARGIN! -253.8% profit margin - thin profits.
PEG Valuation
0/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
5/20
TOO MUCH PUBLIC HOLDING! 46.34% public ownership - higher volatility risk.
Stability Index
2/10
CAUTION! Company made loss in last quarter. Be careful.
Technical Breakdown
Moving Averages
5/10
BEARISH TREND! 50-day average (7.0) is below 200-day average (7.9) - negative signal.
Price Position
2/10
WEAK POSITION! Current price (5.9) is below both moving averages.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
0/10
POOR YEAR! Stock declined 50.5% in the last year.
Volume Sentiment
25/30
BULLISH SENTIMENT! In last 30 days: 10 up days, 15 down days. Avg volume on up days: 41,453 vs down days: 31,581. Ratio: 1.31x
RSI
5/5
OVERSOLD! RSI at 18.7 - potential bounce opportunity.
52W Range
1/5
WEAK! Trading at 2.6% of 52W range - near yearly lows.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 9.7% (1 week), 17.5% (1 month), 20.3% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.60 - stable stock, less market risk.
Peer Comparison
Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LASA | ₹5.90 | – | -253.8% | -42.1% | – | -50.5% | 40 | BREAKDOWN | -82.9% | -14.3% | -94.0% | -1,300.0% |
| VIVIMEDLAB | ₹5.50 | – | -231.3% | -27.9% | – | +12.7% | 42 | BREAKDOWN | +2,526.8% | +786.1% | -53.1% | -25.0% |
| ORTINGLOBE | ₹15.60 | – | – | -74.4% | – | +31.9% | 52 | APPROACHING SUPPORT | +50.0% | – | – | – |
| MANGALAM | ₹32.60 | – | -16.5% | -14.3% | – | -54.4% | 44 | CONSOLIDATION | -44.9% | -43.3% | -0.2% | -15.2% |
| BIOFILCHEM | ₹32.60 | 108.7 | 1.4% | -1.9% | 70.7% | -23.4% | 54 | HIT RESISTANCE | -95.8% | -50.0% | +93.8% | +63.2% |
| VAISHALI | ₹8.20 | – | 4.1% | 18.0% | -15.2% | -27.4% | 57 | CONSOLIDATION | – | +278.0% | – | -15.0% |
| KREBSBIO | ₹56.00 | – | -55.9% | -23.1% | – | -28.3% | 49 | CONSOLIDATION | -52.8% | +8.7% | +27.3% | +2.9% |
| ALPA | ₹59.50 | 29.2 | 3.8% | 4.3% | 6.1% | -37.0% | 46 | APPROACHING SUPPORT | -91.5% | -28.6% | +25.1% | -23.9% |
Data from TradeAlone · Updated daily
No news tagged for LASA yet.
